Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections. 2015

Morteza Abkar, and Jafar Amani, and Abbas Sahebghadam Lotfi, and Gholamreza Nikbakht Brujeni, and Saeed Alamian, and Mehdi Kamali
Department of Molecular Genetics, Faculty of Basic Sciences, Tarbiat Modares University, Tehran, Iran.

Brucellosis is a world prevalent endemic illness that is transmitted from domestic animals to humans. Brucella spp. exploits urease for survival in the harsh conditions of stomach during the gastrointestinal infection. In this study, we examined the immune response and the protection elicited by using recombinant Brucella urease (rUrease) vaccination in BALB/c mice. The urease gene was cloned in pET28a and the resulting recombinant protein was employed as subunit vaccine. Recombinant protein was administered subcutaneously and intraperitoneally. Dosage reduction was observed with subcutaneous (SC) vaccination when compared with intraperitoneal (IP) vaccination. rUrease induced mixed Th1-Th2 immune responses with high titers of specific IgG1 and IgG2a. In lymphocyte proliferation assay, splenocytes from IP and SC-vaccinated mice displayed a strong recall proliferative response with high amounts of IL-4, IL-12 and IFN-γ production. Vaccinated mice were challenged with virulent Brucella melitensis, B. abortus and B. suis. The SC vaccination route exhibited a higher degree of protection than IP vaccination (p value ≤ 0.05). Altogether, our results indicated that rUrease could be a useful antigen candidate for the development of subunit vaccines against brucellosis.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002003 Brucella abortus A species of the genus BRUCELLA whose natural hosts are cattle and other bovidae. Abortion and placentitis are frequently produced in the pregnant animal. Other mammals, including humans, may be infected. Bacterium abortus,Brucella melitensis biovar abortus
D002006 Brucellosis Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss. Malta Fever,Undulant Fever,Brucella Infection,Brucellosis, Pulmonary,Cyprus Fever,Gibraltar Fever,Rock Fever,Brucella Infections,Brucelloses,Brucelloses, Pulmonary,Fever, Cyprus,Fever, Gibraltar,Fever, Malta,Fever, Rock,Fever, Undulant,Infection, Brucella,Pulmonary Brucelloses,Pulmonary Brucellosis
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning

Related Publications

Morteza Abkar, and Jafar Amani, and Abbas Sahebghadam Lotfi, and Gholamreza Nikbakht Brujeni, and Saeed Alamian, and Mehdi Kamali
July 2018, Immunology letters,
Morteza Abkar, and Jafar Amani, and Abbas Sahebghadam Lotfi, and Gholamreza Nikbakht Brujeni, and Saeed Alamian, and Mehdi Kamali
November 2014, Vaccine,
Morteza Abkar, and Jafar Amani, and Abbas Sahebghadam Lotfi, and Gholamreza Nikbakht Brujeni, and Saeed Alamian, and Mehdi Kamali
November 2014, Molecular immunology,
Morteza Abkar, and Jafar Amani, and Abbas Sahebghadam Lotfi, and Gholamreza Nikbakht Brujeni, and Saeed Alamian, and Mehdi Kamali
February 2020, Journal of biotechnology,
Morteza Abkar, and Jafar Amani, and Abbas Sahebghadam Lotfi, and Gholamreza Nikbakht Brujeni, and Saeed Alamian, and Mehdi Kamali
January 2015, Journal of veterinary science,
Morteza Abkar, and Jafar Amani, and Abbas Sahebghadam Lotfi, and Gholamreza Nikbakht Brujeni, and Saeed Alamian, and Mehdi Kamali
January 2012, PloS one,
Morteza Abkar, and Jafar Amani, and Abbas Sahebghadam Lotfi, and Gholamreza Nikbakht Brujeni, and Saeed Alamian, and Mehdi Kamali
July 1996, Vaccine,
Morteza Abkar, and Jafar Amani, and Abbas Sahebghadam Lotfi, and Gholamreza Nikbakht Brujeni, and Saeed Alamian, and Mehdi Kamali
June 2017, Microbial pathogenesis,
Morteza Abkar, and Jafar Amani, and Abbas Sahebghadam Lotfi, and Gholamreza Nikbakht Brujeni, and Saeed Alamian, and Mehdi Kamali
March 2011, FEMS immunology and medical microbiology,
Morteza Abkar, and Jafar Amani, and Abbas Sahebghadam Lotfi, and Gholamreza Nikbakht Brujeni, and Saeed Alamian, and Mehdi Kamali
June 2012, Vaccine,
Copied contents to your clipboard!